View More Recent Stories

Oct 30, 2024 06:05AM Organon (OGN) Announces FDA Acceptance of BLA for HLX14
Oct 28, 2024 09:25AM Organon (OGN) Completes Acquisition of Dermavant
Oct 7, 2024 09:16AM TD Cowen Reiterates Hold Rating on Organon & Co. (OGN)
Sep 30, 2024 06:06AM Organon (OGN) Reports Primary Endpoint Met in Phase 3 Comparative Clinical Study of HLX11
Sep 23, 2024 04:27PM Organon (OGN) enters merger agreement with Dermavant Sciences
Sep 18, 2024 07:30AM Organon (OGN) to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA Cream, 1%
Sep 6, 2024 03:35AM JPMorgan Downgrades Organon & Co. (OGN) to Underweight
Aug 25, 2024 02:00AM 3 ways to gain stock market exposure to the fertility theme
Aug 20, 2024 07:31AM Organon (OGN) and Lilly (LLY) Expand Migraine Commercialization Agreement to 11 Additional Markets
Aug 6, 2024 07:37AM Organon (OGN) Tops Q2 EPS by 4c ; Offers Guidance
Jul 24, 2024 11:00PM These stocks offer you exposure to rising demand for fertility treatment – Barclays
View More Recent Stories